Skip to main content

Cyclic and Constrained Peptides

Cyclic and Constrained Peptides: Choosing a Strategy

Most short peptides are flexible, and flexibility costs you twice: the peptide pays an entropic penalty every time it binds, and proteases find an extended chain easy to cut. Constraining a peptide addresses both. This hub compares the main ways to do it, what each one costs to make, and how to decide which fits your sequence.

Pick by what you need:
  • Reproduce a native disulfide → disulfide cyclization, below
  • Maximum protease resistance → head-to-tail, below
  • Hold a helix together → side-chain bridges and staples, below
  • Just stop the ends being chewed → terminal capping first
  • Order a disulfide peptide → disulfide synthesis service

Why constraint helps

A flexible peptide in solution samples a very large number of conformations, and only a small fraction of them resemble the shape that binds a target. Locking the chain into, or close to, the binding conformation reduces the entropy lost on binding, which can improve affinity without changing a single side chain. The same rigidity tends to improve protease resistance, because most proteases need to thread an extended stretch of backbone through their active site, and a constrained ring does not present one.

Neither benefit is guaranteed. A constraint applied in the wrong place can lock the peptide into a shape that does not bind at all, which is why constrained analogues are normally made as a small set rather than one compound. The background on why short peptides are flexible in the first place is on our peptide folding page.

The four main strategies

Four ways to constrain a peptide. A disulfide joins two cysteine side chains and is reducible; with more than one pair the pairing must be directed. A head-to-tail cycle joins the N-terminus to the C-terminus through the backbone, leaving no free ends, and is the most protease-resistant. A side-chain lactam joins a lysine to an aspartate or glutamate, using up two side chains. A staple is a hydrocarbon bridge across one turn of a helix.
The same chain, constrained four ways. Which one suits a sequence depends on whether the constraint has to be reversible, whether the termini are needed, and which side chains the target uses.
StrategyWhat is joinedBest forWatch out for
Disulfide Two cysteine side chains Reproducing a native disulfide; a quick, reversible loop Reducible inside cells; with more than one pair, the pairing must be directed
Head-to-tail (backbone) N-terminus to C-terminus Strong protease resistance; no free termini at all Cyclization yield falls for very short sequences; can be slow and low-yielding
Side-chain to side-chain Commonly a lysine amine to an aspartate or glutamate acid, forming a lactam Constraining part of a sequence while leaving the termini free Consumes two side chains, which must not be ones the target needs
Staple A hydrocarbon bridge between two non-natural residues Stabilizing an α-helix Requires special amino acids and extra chemistry; placement must follow the helical turn
A peptide can carry more than one of these. Combining a disulfide with a lactam, for example, is common where a native loop has to be reproduced inside a larger constrained scaffold.

Disulfides: directing the pairing

With one pair of cysteines, oxidation gives one product and the chemistry is routine. With two or three pairs, random oxidation gives a mixture of isomers with the same mass, which mass spectrometry cannot tell apart. The way round this is orthogonal cysteine protection: each pair carries a different protecting group, removed in sequence so that one disulfide is formed and closed before the next is unmasked. That is a design decision, not a detail, and it has to be specified when you order.

Tell us the pairing, not just the positions

A sequence with four cysteines has three possible pairing patterns. If you only give the positions, any of the three could be what arrives. State which cysteine pairs with which, and we will choose the protection scheme that delivers it. For dissolving and handling the result, see dissolving peptides with disulfide bonds.

What constraint does not fix

  • Poor solubility. Cyclization often makes a hydrophobic peptide harder to dissolve, not easier. See hydrophobic peptide handling.
  • Cell entry. Some macrocycles cross membranes well and many do not; rigidity alone does not confer permeability. If entry is the goal, that is a separate design question — see cell-penetrating peptides.
  • A wrong binding epitope. Constraint amplifies whatever conformation it locks in. Map the active region first; our mapping hub covers how.
  • Proteolysis at a single exposed site. If one bond is being cut, a D-amino acid or an N-methyl substitution at that position may be simpler and cheaper than cyclizing. See D-amino acid peptides.

Practical notes on ordering

  • Make the linear parent alongside. Without it you cannot show that the constraint did anything.
  • Expect lower yields. Cyclization is an extra step on an already-finished chain, and some sequences cyclize reluctantly. This affects price and turnaround more than the linear equivalent.
  • Purity is read differently. Isomers of a cyclic peptide can co-elute or separate oddly; ask what the HPLC trace actually shows rather than reading the single number. See quality and documentation.
  • Mass alone will not confirm the pairing. Disulfide isomers are identical in mass; confirming connectivity needs a digest or a dedicated experiment.

Related pages

References

  1. White, C. J. & Yudin, A. K. Contemporary strategies for peptide macrocyclization. Nat. Chem. 3, 509-524 (2011).
  2. Driggers, E. M., Hale, S. P., Lee, J. & Terrett, N. K. The exploration of macrocycles for drug discovery. Nat. Rev. Drug Discov. 7, 608-624 (2008).
  3. Góngora-Benítez, M., Tulla-Puche, J. & Albericio, F. Multifaceted roles of disulfide bonds. Peptides as therapeutics. Chem. Rev. 114, 901-926 (2014).
  4. Walensky, L. D. & Bird, G. H. Hydrocarbon-stapled peptides: principles, practice, and progress. J. Med. Chem. 57, 6275-6288 (2014).

Frequently asked questions

Why constrain a peptide?

A flexible peptide loses entropy when it binds, and an extended backbone is easy for proteases to cut. Locking the chain near its binding conformation can improve affinity without changing any side chain, and usually improves protease resistance at the same time.

What is the difference between a disulfide and a head-to-tail cyclic peptide?

A disulfide joins two cysteine side chains and can be reduced, including inside cells. A head-to-tail cyclic peptide joins the N-terminus to the C-terminus through the backbone, leaves no free termini, and is not reversible.

How do I get a specific disulfide pairing?

By orthogonal cysteine protection: each pair carries a different protecting group, removed in sequence so one disulfide is formed and closed before the next is unmasked. Specify which cysteine pairs with which when ordering, since a four-cysteine sequence has three possible patterns.

Can mass spectrometry confirm which disulfides formed?

No. Disulfide isomers have identical masses. Confirming connectivity requires a digest or a dedicated experiment.

Will cyclization make my peptide cell-permeable?

Not reliably. Some macrocycles cross membranes well and many do not. Rigidity alone does not confer permeability, and cell entry is a separate design question.

Research use only. LifeTein peptides and proteins are supplied for laboratory research use. They are not for human or veterinary use, and not for diagnostic or therapeutic use. See our research use policy.